Novo Nordisk

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic conditions: haemophilia, growth disorders and obesity. Headquartered in Denmark, Novo Nordisk employs approximately 39,000 people in 75 countries and markets its products in more than 180 countries.
Bagsvaerd, DK
Size (employees)
40,638 (est)+3%
Novo Nordisk was founded in 1923 and is headquartered in Bagsvaerd, DK

Key People at Novo Nordisk

Lars Rebien Sørensen

Lars Rebien Sørensen

President & Chief Executive Officer
Jesper Brandgaard

Jesper Brandgaard

EVP and Chief Financial Officer
Maziar Mike Doustdar

Maziar Mike Doustdar

EVP of International Operations
Lars Fruergaard Jørgensen

Lars Fruergaard Jørgensen

EVP Corporate Developemnt
Jesper Høiland

Jesper Høiland

Jakob Riis

Jakob Riis

EVP China, Pacific & Marketing

Novo Nordisk Office Locations

Novo Nordisk has offices in Bagsvaerd, Burlington, Oklahoma City, Rochester and in 122 other locations
Bagsvaerd, DK
Oklahoma City, US
New York, US
Virginia Beach, US
Milwaukee, US
Dayton, US
Rochester, US
Plainsboro, US
Mississauga, CA
Mainz, DE
AV Alphen aan den Rijn, NL
Bangalore, IN
Tokyo, JP
Salt Lake City, US
Burlington, US
Roanoke, US
Columbus, US
Beijing, CN
Charleston, US

Novo Nordisk Metrics

Novo Nordisk Summary

Market capitalization

$89.2 B

Closing share price

Novo Nordisk's current market capitalization is $89.2 B.

Novo Nordisk Market Value History

Novo Nordisk Online Presence

Novo Nordisk News

Novo Nordisk Company Life

You may also be interested in